Innoveix Pharmaceuticals product recalled over sterility concerns
- Recall date
- July 9, 2021
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- Innoveix Pharmaceuticals Inc recalls Compounded Lyophilized Semorelin/Ipamorelin 3 mg For subcutaneous or intramuscular injection, Rx Only, Compounded by: I…
- Recall number
- D-0692-2021
- FDA classification
- Class II
- Brand / firm
- Innoveix Pharmaceuticals Inc
- Sold / distributed
- Nationwide within the United States
Why it was recalled
Lack of Assurance of Sterility
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Compounded Lyophilized Semorelin/Ipamorelin 3 mg For subcutaneous or intramuscular injection, Rx Only, Compounded by: Innoveix Addison, TX 75001 800-370-1910
Get recall alerts
Free email alert whenever Innoveix Pharmaceuticals Inc has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Innoveix Pharmaceuticals Inc